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ABSTRACT BKvirus(BKV)isthecausativeagentforpolyomavirus-associatednephropathy,aseverediseasefoundinrenaltrans-
plantpatientsduetoreactivationofapersistentBKVinfection.BKVreplicationreliesontheinteractionsofBKVwithmany
nuclearcomponents,andsubnuclearstructuressuchaspromyelocyticleukemianuclearbodies(PML-NBs)areknowntoplay
regulatoryrolesduringanumberofDNAvirusinfections.Inthisstudy,weinvestigatedtherelationshipbetweenPML-NBsand
BKVduringinfectionofprimaryhumanrenalproximaltubuleepithelial(RPTE)cells.WhilethelevelsofthemajorPML-NB
proteincomponentsremainedunchanged,BKVinfectionofRPTEcellsresultedindramaticalterationsinboththenumberand
thesizeofPML-NBs.Furthermore,twonormallyconstitutivecomponentsofPML-NBs,Sp100andhDaxx,becamedispersed
fromPML-NBs.Todeﬁnetheviralfactorsresponsibleforthisreorganization,weexaminedthecellularlocalizationoftheBKV
largetumorantigen(TAg)andviralDNA.TAgcolocalizedwithPML-NBsduringearlyinfection,whileanumberofBKVchro-
mosomeswereadjacenttoPML-NBsduringlateinfection.WedemonstratedthatTAgalonewasnotsufﬁcienttoreorganize
PML-NBsandthatactiveviralDNAreplicationisrequired.KnockdownofPMLproteindidnotdramaticallyaffectBKVgrowth
inculture.BKVinfection,however,wasabletorescuethegrowthofanICP0-nullherpessimplexvirus1mutantwhosegrowth
defectwaspartiallyduetoitsinabilitytodisruptPML-NBs.WehypothesizethattheantiviralfunctionsofPML-NBsareinacti-
vatedthroughreorganizationduringnormalBKVinfection.
IMPORTANCE BKvirus(BKV)isahumanpathogenthatcausesseverediseases,includingpolyomavirus-associatednephropathy
inkidneytransplantpatientsandhemorrhagiccystitisinbonemarrowtransplantrecipients.HowBKVreplicationisregulated
andtheeffectsofalyticBKVinfectiononhostcellsatthemolecularlevelarenotwellunderstood.Currently,thereisnospeciﬁc
antiviraltreatmentforBKV-associateddisease,andabetterunderstandingofthecompletelifecycleofthevirusisnecessary.
Here,wereporttheinterplaybetweenBKVandoneoftheregulatorystructuresinthehostcellnucleus,promyelocyticleukemia
nuclearbodies(PML-NBs).OurresultsshowthatBKVinfectionreorganizesPML-NBsasastrategytoinactivatethenegative
functionsofPML-NBs.
Received 11 January 2011 Accepted 13 January 2011 Published 8 February 2011
Citation Jiang, M., P. Entezami, M. Gamez, T. Stamminger, and M. J. Imperiale. 2011. Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus
infection. mBio 2(1):e00281-10. doi:10.1128/mBio.00281-10.
Editor Rozanne Sandri-Goldin, University of California, Irvine
Copyright © 2011 Jiang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported
License, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Address correspondence to Michael J. Imperiale, imperial@umich.edu.
B
K virus (BKV) is a ubiquitous human polyomavirus that nor-
mally persists in the urinary tract of healthy individuals with-
out causing any disease. Under immunosuppressed conditions,
particularly in kidney transplant patients, BKV can reactivate
from a persistent to a lytic infection in renal proximal tubule ep-
ithelial(RPTE)cells(1).Thisreactivationcancauseseveredisease,
including polyomavirus-associated nephropathy (PVAN); ~90%
of patients who develop PVAN will lose their graft (2). BKV-
relateddiseasehasbecomeaseriousconcernduetoanincreasein
the number of transplants performed and improvements in the
immunosuppressive regimens used in these procedures (3). Un-
fortunately, little is known about how BKV switches from a per-
sistent to a lytic infection in these cells, and there is currently no
speciﬁc antiviral treatment available (4). Our laboratory has de-
veloped a cell culture system using primary human RPTE cells to
analyze BKV infection (5). BKV grows lytically in these cells, and
the morphology of BKV-infected cells is similar to that seen in
PVAN patient kidneys. This system provides a ﬁrst step towards
gaining a complete picture of the BKV life cycle.
BKV begins its infectious life cycle by binding to cellular gan-
glioside receptors, followed by internalization and intracellular
trafﬁcking prior to delivery of its genome to the nucleus (6–8).
Once inside the nucleus, viral early proteins are expressed and
interact with various nuclear components to create an optimal
environmentconducivetoviralreplication.Forexample,thelarge
tumor antigen (TAg) interacts with members of the retinoblas-
toma susceptibility protein (pRb) family to alleviate E2F-
mediated transcription inhibition. TAg also binds to p53 and dis-
rupts the ability of p53 to activate transcription of its target genes
(reviewed in reference 9). The result of these interactions is to
drivethecellsintoandkeepthecellsinSphasetoprovidethehost
DNA synthetic machinery that is necessary for BKV genome rep-
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eny virus. Small t antigen contributes to BKV replication by or-
chestrating cell cycle progression through inhibiting the
enzymaticactivityofproteinphosphatase2A,increasingthetran-
scriptionofcyclinD1andcyclinA,anddownregulatingthecyclin
kinase inhibitor p27 (10, 11). Simian virus 40 (SV40) TAg also
manipulates the ubiquitin-proteasome pathway by inhibiting
Cul7andSCFFbw7E3ligaseactivities(12).TheinteractionsofTAg
with E3 ligases, however, were examined in transformation stud-
ies, and the implication of these interactions in productive viral
infection remains to be determined.
Promyelocytic leukemia nuclear bodies (PML-NBs), also
known as nuclear domains 10 (ND10), nuclear dots, or PML on-
cogenic domains (PODs), represent a potential obstacle for BKV
replication. PML-NBs were identiﬁed almost 20 years ago (13),
and a diverse array of functions have been assigned to these dy-
namic,small,punctatesubnuclearstructures,includingtranscrip-
tion regulation, apoptosis, DNA damage response, oncogenesis,
and chromatin remodeling (reviewed in references 14 and 15).
Their name is derived from the major component of this struc-
ture, the PML protein, which was discovered as a fusion protein
withtheretinoicacidreceptorthroughachromosomaltransloca-
tioneventinpatientswithacutepromyelocyticleukemia(16,17).
PML-NBs are complicated multiprotein complexes that are
present in almost all cell types examined so far (13). They have a
dynamic composition that changes upon various stress condi-
tions,suchasheatshockandDNAdamage,andthelistofproteins
that are found to be present in or associated with PML-NBs is
growing (reviewed in references 14 and 18). Several proteins, in-
cluding the transcriptional regulators hDaxx and Sp100, are con-
stitutivelypresentinPML-NBs,whileothersarefoundonlyunder
certain stress conditions (19). The identiﬁcation of a functional
linkbetweenPML-NBsandviralinfectionsbeganwiththediscov-
eriesthatherpessimplexvirus1(HSV-1)infectiondestroysPML-
NBs (20) and that PML-NBs are the nuclear deposition and rep-
lication site for a number of other DNA viruses (21–23). Later, it
wasdemonstratedthatPML-NBspossessbothintrinsicandinter-
feron (IFN)-mediated antiviral effects against several DNA and
RNA viruses (15, 18, 24). There is also limited evidence that cer-
tain PML isoforms may facilitate bovine papillomavirus gene ex-
pression (25).
TherolesthatPML-NBsplayinpolyomavirusinfectionareless
well characterized, but PML-NBs seem to be associated with all
stages of the viral life cycle. In SV40-infected HEp-2 epidermoid
carcinoma cells, some intense TAg areas are found juxtaposed to
PML-NBs (21). In addition, in situ hybridization revealed that
most of the DNA replication centers are adjacent to PML-NBs;
however,thereisnodisruptionofPML-NBsinthesecells.Usinga
plasmid-based -galactosidase expression system, Tang et al.
demonstrated that the origin of SV40 DNA replication and TAg
expression are required for targeting of -galactosidase tran-
scripts to PML-NBs (26). The accumulation of transcripts at
PML-NBs can be disrupted by inhibiting DNA replication, which
led the authors to conclude that TAg-directed DNA replication
rather than transcription occurs in the vicinity of PML-NBs (26).
ForBKV,ithasbeenshownbyBrdUpulse-labelingthatPML-NBs
associate with newly synthesized viral DNA and that a portion of
the DNA within these PML-NBs is single stranded (27). The au-
thors hypothesized that the single-stranded DNA may represent
recombination intermediates that accumulate during a
replication-induced DNA repair process. Depleting PML protein
usingsmallinterferingRNA(siRNA)hadlittleeffectonviralDNA
replication(27).Thesestudies,however,wereconductedwithpri-
mary brain cells and breast cancer cell lines, which are not the
naturalhostcellsforBKV;therefore,thebiologicalsigniﬁcanceof
these results is unclear. For another human polyomavirus, JC vi-
rus(JCV),infectionalsodoesnotcausedegradationorrelocaliza-
tion of PML in the human glial cell line SVG-A, and short hairpin
RNA (shRNA) knockdown of PML does not have signiﬁcant ef-
fects on JCV replication (28). The inhibition of JCV by IFN-,
however, can be reversed by arsenite treatment, which degrades
PMLprotein(28).Finally,themajorandminorcapsidproteinsof
JCV have been found to accumulate at PML-NBs in both trans-
fected cells and oligodendrocytes derived from patients with pro-
gressivemultifocalleukoencephalopathy,adiseasecausedbyJCV
(29). Both capsid proteins and virus-like particles were seen at
discretelocationsalongtheinnernuclearperiphery,leadingtothe
conclusion that PML-NBs may serve as a scaffold for JCV assem-
bly (29, 30).
In this study, we characterized the effects of BKV infection on
PML-NBs in its natural host, RPTE cells. Our results show that
BKV infection caused a dramatic reorganization of PML-NBs,
with a decrease in PML-NB number and an increase in size. In
addition,bothhDaxxandSp100werefoundtobedispersedfrom
PML-NBs. This reorganization required BKV DNA replication;
consistent with this, BKV DNA foci were found adjacent to PML-
NBsduringlateinfection.Moreimportantly,wepresentevidence
thatthereorganizationofPML-NBsisastrategythatBKVusesto
inactivate intrinsic antiviral functions of PML-NBs.
RESULTS
BKVinfectioninRPTEcellsaltersboththenumberandthesize
of PML-NBs. Various DNA virus infections have been shown to
cause changes to PML-NBs. For example, PML-NBs are reorga-
nized into track-like structures upon adenovirus (Ad) infection
(23). This is accomplished by the early viral protein E4 ORF3 (23,
31). The HSV-1 regulatory protein ICP0 induces the degradation
ofPMLinaproteasome-dependentmanner(20,32).Inthecaseof
humancytomegalovirus(HCMV),PML-NBsaredispersedintoa
diffusenucleoplasmicformbythemajorimmediate-earlyprotein
IE1, which interferes with the SUMOylation of PML (33, 34). To
begin our characterization of the interplay between BKV and
PML-NBs,weﬁrstexaminedtheeffectsofBKVinfectionofRPTE
cellsonthemorphologyofPML-NBs.WevisualizedPML-NBsat
2 days postinfection (dpi) by immunostaining for the major de-
ﬁning component of PML-NBs, the PML protein (Fig. 1A). The
viral early protein TAg was used as a marker for infected cells. In
mock-infected cells, PML-NBs displayed a small, punctate, nu-
clear staining pattern. In TAg-positive cells, however, there was a
dramaticdifferenceintheappearanceofPML-NBs.Overall,there
were fewer PML-NBs in each nucleus, and some of the PML-NBs
were larger than the ones in the mock-infected cells.
Wequantiﬁedboththenumber(Fig.1B)andthesizedistribu-
tion (Fig. 1C) of PML-NBs in both mock- and BKV-infected
RPTE cells. There was an approximately 60% reduction in the
average number of PML-NBs in the cells that were positive for
TAg. To graph the size distribution of PML-NBs, we grouped
PML-NBs based on their diameter measurements. PML-NBs that
were larger than 1 m in diameter were found exclusively in the
BKV-infected samples. Cells that were assayed at 3 dpi showed a
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than at 2 dpi (data not shown).
LevelsandrelativelocalizationofPML-NBcomponentsdur-
ing BKV infection. To determine whether the decrease in
PML-NB number was due to a decrease in PML protein level, we
harvested total cell proteins from mock- and BKV-infected RPTE
cells over a 3-day time course. The proteins were immunoblotted
forthreeofthemajorcomponentsofPML-NBs:PML,hDaxx,and
Sp100. Both PML and Sp100 have multiple isoforms produced
from alternative mRNA splicing (35, 36), and the antibodies that
weusedrecognizealltheisoforms.TAgexpressionwasalsoexam-
ined as a marker for the progression of the infection. No signiﬁ-
cant differences were seen in the levels of any PML-NB proteins
between mock- and BKV-infected samples, although there was a
reproducible slight increase of hDaxx in the BKV-infected sam-
plescomparedtothelevelinthemock-infectedsamplesat2and3
dpi (see Fig. S1 in the supplemental material).
We then determined whether the enlarged PML-NBs in the
infected cells have components similar to those of normal PML-
NBs. We ﬁrst examined the relative localizations of PML and
hDaxx over the course of BKV infection, since hDaxx is consid-
eredaconstitutivecomponentofPML-NBsundernormalgrowth
conditions (37). In mock-infected cells, both hDaxx and PML
displayed similar small punctate patterns, and most of the signals
from these two proteins are colocalized with or adjacent to each
other (Fig. 2). RPTE cells that were infected with BKV for 1 day
showed a staining pattern similar to that of the mock-infected
samples.By2dpi,enlargedPML-NBsstartedtoappear,andthese
PML-NBs became more evident by 3 dpi, with some PML-NBs
displaying a ring-like structure (Fig. 2 and 3A, arrows and insets).
Intriguingly, as the PML-NBs enlarged, hDaxx began to disperse
from the PML. There was still partial colocalization of PML and
hDaxxinthe2-dpisamples,butby3dpi,thepercentageofhDaxx
foci that were colocalized with or adjacent to PML foci signiﬁ-
cantlydecreasedcomparedtothelevelformock-infectedcells(see
Fig. S2A in the supplemental material). Similarly, Sp100 was also
found to separate from PML by 3 dpi (Fig. S2B). SUMO-1, how-
ever, remains associated with PML throughout the course of in-
fection (Fig. S2C). Due to the fact that hDaxx and Sp100 separate
fromPML,theseresultssuggestthattheenlargementofPML-NBs
is not simply the fusion of preexisting PML-NBs.
Dynamic localization of PML, TAg, and BKV DNA. We then
determined the localization of PML and viral factors to obtain
insight into how the reorganization of PML-NBs occurs. Many
FIG 1 PML-NBs are altered morphologically during BKV infection. (A)
RPTEcellsweremockinfectedorinfectedwithBKVatanMOIof5IU/cellfor
48 h. The cells were ﬁxed and immunostained for PML protein (green) and
TAg (red). Images were obtained with a 40 objective on an Olympus BX41
ﬂuorescence microscope. Scale bar, 10 m. The number (B) and the size dis-
tribution(C)ofPML-NBswerequantiﬁedasdescribedinMaterialsandMeth-
ods. For panel B, the average number of PML-NBs in the mock-infected cells
wassetto100%,andPwas0.06.Atleast50cells(B)or200PML-NBs(C)were
counted or measured, respectively, in each sample. Each bar represents the
average of results from three independent experiments, and the error bars
represent the standard deviation (SD) values.
FIG 2 PML and hDaxx localization during BKV infection. RPTE cells were
mock infected or infected with BKV as described in the legend to Fig. 1. Con-
focal images of cells that were ﬁxed at the indicated time points postinfection
andimmunostainedforhDaxx(green)andPMLprotein(red)areshown.The
arrow points to an enlarged ring-like PML-NB, which is magniﬁed 2-fold in
the inset. Scale bar, 10 m.
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they disrupt or reorganize these nuclear structures (reviewed in
reference 19). We therefore ﬁrst examined the relative localiza-
tions of PML and the BKV master regulatory protein TAg by im-
munostaining (Fig. 3A). TAg sets up the host environment for
BKVreplicationbyinactivatingpRbandp53andalsoparticipates
in the initiation of viral DNA replication (9). During early infec-
tion (1 dpi), TAg appeared as small nuclear foci, many of which
were colocalized with PML nuclear foci. Starting from 2 dpi, the
majority of the TAg signals became diffused throughout the nu-
cleus and there were several nuclear exclusion areas that were de-
voidofTAg.TheTAg-excludedareascontinuedtoincreaseinsize
to3dpi.PMLlocalizationdidnotappeartoberandomrelativeto
the TAg staining; most of PML-NBs were found at the periphery
of these TAg-excluded areas (Fig. 3A, arrow). We also examined
the relative localizations of hDaxx and TAg (see Fig. S3 in the
supplemental material); hDaxx colocalized with small TAg foci
throughout the infection; no obvious association, however, was
seenbetweenhDaxxandthediffuselystainingTAgobserveddur-
ing late infection.
Since the timing of PML-NB enlargement (2 dpi) coincides
with the detection of BKV DNA replication (5), we also investi-
gated the relative localizations between PML and viral DNA as
visualized by ﬂuorescent in situ hybridization (FISH) (Fig. 3B).
We could not consistently detect viral DNA signals by FISH at 1
dpi,whichispriortotheonsetofDNAreplication(5).Therefore,
theFISHsignalsthatwedetectedat2and3dpiwerelikelymostly
newlyreplicatedviralDNA.NoFISHsignalswereseeninDNase-
treated or nondenatured samples (data not shown), conﬁrming
that the signals were not from detection of viral RNA. A dynamic
pattern was also observed between PML and viral DNA. In some
of the cells at 2 dpi, viral DNA was present as distinct nuclear foci
(Fig.3B,2dpi-1).Thesefociwerefoundtobeadjacentto,butnot
colocalizedwith,PMLfoci.Insomeinfectedcellsat2dpithathad
progressed to a later point in the infection, as judged by nuclear
enlargement (5), the DNA staining was more intense and was
localized in a pattern that was similar to that of TAg, with areas of
apparent nuclear exclusion (compare Fig. 3B, 2 dpi-2, and 3A, 2
dpi).By3dpi,mostoftheDNAsignalswereinseveralbright,large
foci. Some, but not all, of these foci were found to be close to
enlargedPMLfoci(Fig.3B,3dpi).Takentogether,PMLfociwere
seen close to both TAg and viral DNA, albeit at different times
during the infection.
ReorganizationofPML-NBsrequiresBKVDNAreplication.
Given the timing of the PML-NB reorganization, we determined
whether this reorganization required BKV DNA replication. We
treated cells with the DNA replication inhibitor AraC, which
blocks replication by interfering with topoisomerase I. This drug
effectivelyinhibitedBKVDNAreplicationasassayedbyreal-time
PCR(seeFig.S4Ainthesupplementalmaterial)anddidnotcause
signiﬁcant cytotoxicity (80% of the cells were viable compared
totheuntreatedcontrols).ToensurethatDNAreplicationwasthe
onlyvariable,weadjustedthemultiplicitiesofinfection(MOIs)to
keep the levels of TAg protein similar between treated and un-
treated cells, because otherwise the TAg level would be higher in
untreated cells due to genome ampliﬁcation. Western blotting
conﬁrmedthatthelevelsofTAgwereequivalentbetweencellsthat
were infected with a low MOI and had active viral DNA replica-
tion and cells that were infected with a high MOI with DNA rep-
lication blocked (Fig. S4A, inset).
FIG 3 PML protein localization with BKV TAg and DNA. RPTE cells were mock
infected or infected with BKV as described in the legend to Fig. 1 and ﬁxed at the
indicated time points postinfection. Samples were either coimmunostained for
PML (green) and TAg (red) (A) or stained for PML (green) and BKV viral DNA
usingFISH(red)(B),andimagesweretakenusingaconfocalmicroscope.Thearrow
in panel A points to an enlarged ring-like PML-NB, which is magniﬁed 2-fold in the
inset. Scale bar, 10 m. In panel B, “2 dpi-1” and “2 dpi-2” represent early- and late-
infectedcells,respectively,at2dpi.Twodifferentﬁeldsfor3dpiareshown.
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quantiﬁed in these samples (Fig. 4A and B). AraC treatment itself
didnotaffectPML-NBs.IncellsthatwereinfectedwithanMOIof
0.1 infectious units (IU)/cell, there was ~30% reduction in the
average number of PML-NBs. The change was not as dramatic as
that shown in Fig. 1, probably due to the lower MOI used here.
Thisdecrease,however,wasabolishedwhenviralDNAreplication
was inhibited (Fig. 4A). Moreover, enlarged PML-NBs (diame-
ter, 1 m) were present only in cells in which BKV DNA
replicated (Fig. 4B). Similar results were obtained when we
treated the cells with a different DNA replication inhibitor,
aphidicolin,whichinhibitsDNApolymerase(datanotshown).
Finally, we expressed TAg alone in RPTE cells by use of a
lentivirus-based transduction method, and no difference was
seen in either the number or the size of PML-NBs compared to
mock- or empty-vector-transduced cells (Fig. 4C). Together,
these results suggest that TAg alone is not sufﬁcient to reorga-
nize PML-NBs in RPTE cells and that active BKV DNA repli-
cation is necessary for this process.
PML-NBs are not required for BKV growth. To gain a better
understanding of the functional signiﬁcance of PML-NB reorga-
nization, we transduced RPTE cells with a retrovirus expressing
shRNA against PML and assessed the effects on BKV infection.
ThePMLshRNAandcontrolvectorshavepreviouslybeenusedin
primary human ﬁbroblasts to deﬁne the functions of PML in
HCMV infection (38). After puromycin selection of transduced
RPTE cells, there was a downregulation of a majority of the iso-
formsofPML(Fig.5A).AlthoughtwoisoformsofPMLmigrating
at ~80 kDa were still present in the PML knockdown samples,
mostcellsexaminedbyanimmunoﬂuorescenceanalysis(IFA)did
not contain detectable PML-NBs (see Fig. S5A in the supplemen-
tal material; also data not shown). In the PML knockdown sam-
ples, hDaxx had a more speckled nuclear staining pattern than in
the control samples (Fig. S5A), as previously reported (38).
We infected these cells with BKV and harvested total cell pro-
teins at 2 dpi. A lower MOI was used because it has been shown
that the effect of PML knockdown on HCMV infection is more
pronounced when cells were infected at low MOIs (38). Western
blotting demonstrated that there was ~50% reduction of TAg in
thePMLknockdowncells(Fig.5A;seealsoFig.S5Binthesupple-
mental material). We observed a similar reduction of TAg when
weusedpooledsiRNAtoknockdownPML,duringwhichthetwo
isoforms of PML at ~80 kDa were downregulated (data not
shown). PML knockdown also did not affect BKV growth: there
wasonlya2-foldreductionofprogenyvirionsinknockdowncells
at 2 dpi, and no differences were detected at 3 and 4 dpi (Fig. 5B).
BKV infection is able to rescue an ICP0-null mutant of
HSV-1. PML-NBs have intrinsic antiviral activities and are there-
foretargetedbymanyDNAvirusestofacilitatetheprogressionof
theirinfections(15,18).IfthereorganizationofPML-NBsisaway
for BKV to inactivate the antiviral functions of PML-NBs, we
would expect to see no major effect of PML knockdown on BKV
infection, since the PML-NBs have already been disrupted by the
virus.TotestthehypothesisthatBKVinhibitsPML-NBfunction,
therefore, we examined whether BKV infection was able to rescue
the growth defect of an ICP0-null HSV-1 mutant. During HSV-1
infection, ICP0 is targeted to PML-NBs and induces PML degra-
dation(37,39).AnICP0-nullmutantisnotabletodegradePML,
andhence,viralgeneexpressionisrepressed(40,41).Depletionof
PML,however,canpartiallycomplementthegrowthdefectsofan
FIG4 PML-NBreorganizationisdependentonviralDNAreplication.RPTE
cellsweremockinfectedorinfectedwithBKVattheindicatedMOIs.At24hpi,
40 g/ml AraC was added to the indicated samples. Average number (A) and
size distribution (B) of PML-NBs in cells treated or not treated with AraC. At
least 30 cells (A) or 130 PML-NBs (B) were counted or measured in each
sample. Each bar represents the average of results from three independent
experiments, and the error bars represent the SD values. *, P  0.01 for com-
parison to all the other samples. (C) RPTE cells were mock transduced or
transduced with empty-lentivirus control or with lentivirus expressing TAg.
Cells were ﬁxed at 3 days posttransduction and immunostained for PML
(green) and TAg (red). Images were obtained as described in the legend to
Fig. 1. Scale bar, 5 m.
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are counteracted by ICP0 during normal infection (42). There-
fore,wereasonedthattherescueoftheICP0-nullmutantcouldbe
used as an indicator of PML-NB inactivation by BKV.
Because HSV-1 replicates more rapidly than BKV, RPTE cells
were ﬁrst infected with BKV for 3 days and subsequently superin-
fected with wild-type (WT) or ICP0-null mutant HSV-1 at two
different MOIs. Total cell proteins were collected 8 h after HSV
infection and immunoblotted for ICP4 (an immediate-early
HSV-1geneproduct),gB(alateHSV-1geneproduct),ICP0,TAg,
and actin (Fig. 6A). The ICP0 blot conﬁrmed the identities of the
two herpesviruses. Examining ICP4 revealed that BKV infection
did not have any noticeable effect on WT HSV-1 at either MOI
(Fig. 6A, lane 4 versus lane 3 and lane 8 versus lane 7). However,
thereweresigniﬁcantincreasesinICP4intheICP0-nullmutantat
bothMOIs(Fig.6A,lane6versuslane5andlane10versuslane9).
In the case of gB, BKV infection caused a slight increase in WT
HSV-1 at the high MOI (Fig. 6A, lane 8 versus lane 7, and B), but
theinductionofgBwithBKVcoinfectionintheICP0-nullmutant
was much stronger (Fig. 6B). Using IFA, we conﬁrmed that PML
was degraded in the WT-HSV-1-superinfected samples but re-
mained as enlarged structures in the ICP0-null-mutant-
superinfected samples (data not shown). These results corrobo-
rated our hypothesis that the reorganization of PML-NBs during
BKV infection is a novel form of functional inactivation of these
structures.
FIG5 PMLknockdowndoesnotaffectBKVreplication.(A)RPTEcellswere
transduced with the indicated retroviruses (vector, shRNA control, and PML
shRNA) and infected with BKV at an MOI of 0.5 IU/cell. Total proteins were
harvestedat2dpiandprobedforPML,TAg,andactin.(B)Retrovirallytrans-
duced RPTE cells were infected as described for panel A, viral lysates were
harvestedat2to4dpi,andprogenyproductionwasdeterminedbyanIUassay.
Datawerenormalizedtoproteinconcentration,andthevaluesfortheempty-
vector samples were set to 1 for each time point. Each bar represents the
average of results from at least four independent experiments, and the error
bars represent the SD values. The P values are 0.02, 0.49, and 0.60 for 2, 3, and
4 dpi, respectively (for comparison of PML knockdown sample to shRNA
control sample).
FIG 6 BKV infection partially complements an ICP0-null HSV-1 mutant.
(A)RPTEcellsweremockinfectedorinfectedwithBKVatanMOIof5IU/cell
for 3 days. The cells were subsequently superinfected with WT or ICP0-null
HSV-1 at the indicated MOIs. Total cell proteins were harvested 8 h after
HSV-1 infection and immunoblotted for ICP4, gB, ICP0, TAg, and actin. (B)
Quantitation of gB induction by BKV infection. Western blots of samples
infected with an MOI of 3 PFU/cell HSV-1 were probed for gB and GAPDH
and visualized using the Odyssey imaging system. The fold induction of gB
caused by BKV infection was quantiﬁed for both WT and ICP0-null HSV-1s
and normalized to the level for the GAPDH loading control. Each bar repre-
sentstheaverageofresultsfromthreeindependentexperiments,andtheerror
bars represent the SD values (P  0.02).
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Toestablishanoptimalenvironmentforreplication,virusesmust
utilizehostcomponentsthatarebeneﬁcialtotheirpropagation;at
the same time, inhibitory host factors need to be inactivated or
destroyedtoensuretheprogressionofthereplicationprocess.We
investigated the effects that BKV infection has on PML-NBs and
therolesthatPML-NBsmightplayinaproductiveBKVinfection.
PML-NBs are multiprotein structures that are able to produce
antiviral effects against both DNA and RNA viruses through var-
ious mechanisms (18). We show here that, similar to other DNA
viruses, BKV causes PML-NBs to reorganize in RPTE cells upon
infection, albeit in a novel manner. Instead of being degraded or
reshaped into track-like structures, PML-NBs in BKV-infected
cells became reduced in number, larger in size, and altered in
composition, although the levels of PML components were un-
changed. The reorganization was accompanied by a functional
change in PML-NBs, as BKV-infected cells were able to comple-
ment the growth defects of an ICP0-null mutant of HSV-1 whose
deﬁciencies lie partially in its inability to destroy the detrimental
PML-NBs. These results suggest that antiviral roles of PML-NBs
aredisruptedbyBKVduringitsinfection.Whileitispossiblethat
functionsofICP0otherthandisruptionofPML-NBsaresupplied
by BKV, our preliminary results show that TAg alone is not sufﬁ-
cient to complement the ICP0-null mutant (data not shown).
PML knockdown, which disrupts PML-NBs, does not seem to
have a major impact on WT BKV growth. These results are con-
sistent with the observations that JCV, another human polyoma-
virus, does not require PML to undergo a productive infection
(28). We hypothesize that PML-NBs are inactivated by BKV and
therefore that PML knockdown does not signiﬁcantly affect BKV
infection. This is similar to inactivation of pRb by SV40 TAg: the
absence of pRb does not enhance TAg-dependent DNA replica-
tion (43). Our data, however, do not rule out the possibility that
low levels of some PML isoforms that persist in the PML knock-
down cells may have additional roles in BKV infection.
PML-NBs were colocalized with or adjacent to BKV compo-
nents,andtheassociationoccursinatemporallycontrolledman-
ner. During the early phase of infection, PML-NBs colocalized
withTAgfoci.Itispossiblethatincomingpolyomavirusgenomes
get deposited at PML-NBs, although unfortunately we could not
consistentlydetectinputviralgenomes.PML-NBsmayprovidean
initial microenvironment that is conducive to early transcription.
This phenomenon has been documented for HCMV, whose
immediate-early transcripts have been found close to PML-NBs
along with the spliceosome assembly factor SC35 and two other
transcription factors (44). In PML knockdown cells infected with
BKV, we detected a 2-fold decrease in TAg levels compared to the
level for control cells. This small decrease was still present in cells
treated with AraC, which rules out the effects of genome ampliﬁ-
cation (data not shown), suggesting that PML may contribute to
the optimal transcription of the TAg gene.
LaterduringBKVinfection,PML-NBreorganizationoccurred
and PML-NBs were detected adjacent to intense BKV DNA foci.
Furthermore, we show here that, unlike for other viruses, BKV
DNA replication was necessary for this process. How viral repli-
cation elicits reorganization is not known, and we are currently
isolating BKV DNA replication mutants to investigate this pro-
cess. It has been suggested that newly replicated single-stranded
DNA accumulates in PML-NBs in BKV-infected cells (27), and
therefore the reorganization of PML-NBs may be coupled to
postreplication DNA-processing events such as recombination to
repair breaks that are generated during replication. We think it is
unlikely that BKV late proteins play a major role in PML-NB re-
organization, because AraC treatment has only a slight effect on
VP1 levels (see Fig. S4B in the supplemental material) and it does
not inhibit SV40 late gene expression (45). During late infection,
weobservethatTAgisexcludedfromcertainareasofthenucleus.
We currently do not know what these TAg-excluded areas repre-
sent, but there is limited electron microscopy and IFA staining
evidenceindicatingthatthesearetheareaswhereviralcapsidpro-
teins and newly produced BKV virions accumulate (data not
shown and reference 46).
AsBKVinfectionprogressedinRPTEcells,thePML-NBscon-
tinued to enlarge to the point that they sometimes formed ring-
like structures. Similar ring-like structures have been reported to
occurinseveralothercases.Forexample,HSV-1genomesinqui-
escently infected cells are found sequestered in PML-NBs with
ring-like structures (47). Unlike for BKV infection, these ring
structures contain hDaxx along with heterochromatin protein
HP1 and conjugated ubiquitin. In addition, the PML-NB ring
surrounds, instead of being juxtaposed to, the HSV-1 DNA (47).
The functional signiﬁcance of this association remains unknown.
Enlarged ring-like PML-NBs are also found in telomerase-
negative tumor cells that maintain their telomeres using the
recombination-mediated alternative-lengthening-of-telomeres
(ALT) mechanism (48). These PML-NBs are called ALT-
associatedPML-NBsandcontaintelomericDNA,telomerebind-
ing proteins, and proteins involved in DNA recombination, such
as RAD51 and RAD52. Furthermore, a similar PML-NB ring
structure has been described to occur in lymphocytes of patients
suffering immunodeﬁciency, centromeric instability, and facial
dysmorphy syndrome (49). Interestingly, the authors discovered
that these PML-NBs also contain DNA and may function in the
reestablishment of the condensed heterochromatic state on the
enclosed DNA. High-resolution 4Pi ﬂuorescence microscopy has
revealed that PML-NBs have a distinct outer shell and may sur-
round core structures such as telomeric DNA (50). Taken to-
gether, the common features of the enlarged, ring-like PML-NBs
are that they are all associated with DNA and that DNA recombi-
nation or chromatin remodeling processes may occur within or
adjacent to them. It is possible that the ring-like PML-NBs de-
tectedinBKVinfectionalsorepresentsitesthatallowviralDNAto
undergo postreplication recombination events or chromatin
modiﬁcation.
It is intriguing that hDaxx and Sp100 separate from PML dur-
ing BKV infection at a time that correlates with viral DNA repli-
cation and PML-NB enlargement. During Ad infection, other
PML-NB components, Sp100 and NDP55, relocate from PML-
NBs to viral replication domains (23). Mutational analyses have
revealed that Ad DNA replication may be required for the redis-
tribution of these proteins and that formation of PML-NB tracks
may be required only for early replication. There are two major
questionsremainingwithregardtotheredistributionofPMLand
hDaxx/Sp100 during BKV infection. First, what is the functional
signiﬁcance of this event? It is possible that hDaxx/Sp100 play an
inhibitory role to combat BKV replication and that the detach-
ment of these proteins from PML-NBs counters those negative
effects. Alternatively, the dissociated hDaxx/Sp100 may play a
positiveroleduringBKVlateinfection.Thesecondquestionseeks
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curs.ItisknownthatSUMOylationofPMLisrequiredforforma-
tion of PML-NBs and for recruitment of hDaxx to PML-NBs
through interactions with a SUMO-interacting motif in hDaxx
(37, 51). Both HCMV and Epstein-Barr virus have the capacity to
regulate the SUMOylation of PML, disrupting inhibitory PML-
NBs (34, 52, 53). BKV infection did not seem to cause a dramatic
change in the SUMOylation status of PML (see Fig. S1 in the
supplementalmaterial);therefore,additionalstudiesarerequired
to determine how the infection causes PML and hDaxx/Sp100 to
dissociate, which might help explain how reorganization leads to
functional inactivation of PML-NBs.
MATERIALS AND METHODS
Cell culture, viruses, and plasmids. Primary human RPTE cells were
maintained in renal epithelial cell growth medium (REGM) as previously
described (54). Vero cells and 293T cells were maintained in Dulbecco’s
modiﬁedEaglemedium(Gibco)containing10%fetalbovineserum(Hy-
Clone), 100 U/ml penicillin, and 100 g/ml streptomycin (Cambrex).
293TT cells (a gift from Chris Buck, NIH) were maintained in the same
medium with 400 g/ml hygromycin (55). All cells were grown at 37°C
with 5% CO2 in a humidiﬁed incubator.
BKV (Dunlop) was grown and puriﬁed and its titer determined using
aninfectiousunit(IU)assayaspreviouslydescribed(8).Wild-type(WT)
andICP0-nullmutantHSV-1swereobtainedfromNealDeLuca,Univer-
sityofPittsburgh.shRNAemptyplasmid(pSIREN-RetroQ),shRNAcon-
trol plasmid (psiC), and PML shRNA plasmid (psiPML2) were described
previously (56). The retrovirus packaging plasmid pLP/VSVG was from
Invitrogen, and pUMVC3-gag-pol was obtained from Alice Telesnisky,
University of Michigan. Lentivirus packaging plasmids pMDLg-pRRE,
pRSV-Rev, and pCI-VSVG as well as the lentiviral expression plasmid
pLentilox-IRES-PURO (pLL-Puro) were obtained from the Vector Core,
University of Michigan.
The BKV TAg cDNA was cloned using fusion PCR. The 5= untranslated
region(5=-UTR)andexon1ofTAgwerePCRampliﬁedusingprimersBKV-
TAg-ext-F-new (5= GGCTGCATTCCATGGGTAAGCAGCT 3=) and BK-
TAg-int-R (5= AGGTTGGCACCTCTGAGCTACTCCAGGT 3=). Exon 2
andthe3=-UTRwerePCRampliﬁedusingprimersBK-TAg-int-F(5=GTAG
CTCAGAGGTGCCAACCTATGGAACA 3=) and BK-TAg-ext-R (5= CCAG
GGGACCCAGATATGATAAGA 3=). The two PCR products were fused to-
getherinaseparatePCRusingprimersF-XhoI-5UTR(5=GACTCGAGGCC
TCCACCCTTTCTCTCAA 3=) and BK-TAg-R-BamHI (5=CAGGATCCTT
ATTTTGGGGGTGGTGT 3=). The ﬁnal PCR product was cloned into the
pCR2.1-TOPO vector (Invitrogen) and subcloned into pLL-Puro via the
XhoI and BamHI restriction sites.
Antibodies. The following antibodies and concentrations were used
unless otherwise stated: anti-PML (sc-5621; Santa Cruz) for immunoﬂu-
orescence analyses (IFAs; 1:200) and Western blotting (WB; 1:500), anti-
PML (sc-966; Santa Cruz) for IFAs (1:200), anti-Daxx (sc-7152; Santa
Cruz) for IFAs (1:50), anti-Daxx (no. 1094-1; Epitomics) for WB
(1:5,000), anti-SP100 (H00006672-D01P; Novus Biologicals) for IFAs (1:
300) and for WB (1:1,000), anti-SUMO-1 (small ubiquitin-like modiﬁer
1) (sc-5308; Santa Cruz) for IFAs (1:100), anti-TAg pAb416 (57) for IFAs
(1:200) and WB (1:3,000), anti-VP1 (8) for WB (1:5,000), anti-GAPDH
(anti-glyceraldehyde-3-phosphate dehydrogenase; ab9484; Abcam) for
WB (1:10,000), anti--actin (no. 4967; Cell Signaling) for WB (1:5,000),
anti-HSV-1 ICP4 for WB (1:1,000) and ICP0 for WB (1:1,000), anti-
HSV-1gBforWB(1:500);horseradishperoxidase-conjugatedsheepanti-
mouseanddonkeyanti-rabbitIgG(Amersham)forWB(1:2,000-15,000),
andAlexaFluor488goatanti-rabbitandAlexaFluor594goatanti-mouse
IgG(HL) (Invitrogen) for IFAs (1:200). Anti-gB serum was a gift from
Oveta Fuller (University of Michigan), and anti-HSV-1 antibodies were
gifts from Neal DeLuca.
Infectionsanddrugtreatments.Tosynchronizeinfections,70%con-
ﬂuent RPTE cells were prechilled for 15 min at 4°C. The cells were then
infected with puriﬁed BKV diluted in REGM at the indicated multiplici-
ties of infection (MOIs) and incubated for 1 h at 4°C. The viral inoculum
wasremoved,andthecellswerewashedoncewithcoldmedium.Infection
was initiated by adding prewarmed REGM and transferring the cells to
37°C. Total cell proteins and viral lysates were harvested as previously
described (54). For the HSV-1 superinfection experiment, RPTE cells
were ﬁrst infected with BKV for 3 days. Subsequently, the cells were in-
fected with HSV-1 (WT or ICP0-null) at the indicated MOIs and incu-
bated for1ha t37°C. The viral inoculum was then replaced with fresh
REGM, and total cell proteins were harvested at 8 h postinfection (hpi).
Cytosine -D-arabinofuranoside (AraC; Sigma) was reconstituted ac-
cordingtothemanufacturer’srecommendationsandwasaddedat24hpi
at 40 g/ml and present until the time of the assays. The AraC treatment
did not cause signiﬁcant cytotoxic effects, according to a cell metabolism
WST-1 assay (Roche; data not shown).
Western blotting and quantiﬁcation. Total cell proteins were har-
vested, quantiﬁed, and immunoblotted as previously described (8). For
quantitative blots using the Odyssey infrared imaging system, the mem-
brane was processed according to the manufacturer’s instructions
(LI-COR). The following antibodies and concentrations were used: gB,
1:1,000; GAPDH, 1:5,000; and goat anti-rabbit IRDye 680 and goat anti-
mouse IRDye 800CW, both at 1:10,000. The membrane was scanned us-
ing the Odyssey infrared imaging system. The relevant bands were quan-
tiﬁed using the Odyssey software program.
Microscopy and PML-NB measurements. At the indicated time
points postinfection, RPTE cells grown on coverslips (Fisher) were ﬁxed
in ice-cold 95% ethanol and 5% acetic acid for 5 min. Following three
washes with phosphate-buffered saline (PBS), the samples were blocked
with 5% goat serum (Vector Laboratories, Inc.) for1ha troom temper-
ature(RT).Afterbeingblocked,thesampleswereincubatedwithprimary
antibodies and the corresponding secondary antibodies sequentially in
5%goatserumfor1heachatRT,withthreePBSwashesinbetween.Slides
were mounted with ProLong gold antifade reagent with DAPI (4=,6-dia-
midino-2-phenylindole; Invitrogen). For standard ﬂuorescence micros-
copy, slides were examined using an Olympus BX41 microscope with a
Plan 40/0.65 objective or a Plan 100/1.25 oil objective. For laser-
scanning confocal microscopy, all images were obtained using a Zeiss
LSM 510 confocal microscope with a 63/1.2 objective and a 1-m op-
tical section. Images were analyzed and processed using an LSM image
browser (Zeiss).
All PML-NB measurements were obtained using an Olympus BX41
microscope. To determine the number of PML-NBs per cell, images were
takenusinga40objectivefromrandomlydistributedﬁeldsontheslide,
and the number of PML-NBs per cell was counted. To measure the aver-
age size of PML-NBs, images were obtained using a 100 objective. A
ruler was imprinted onto each image using the DP Controller software
program (Olympus). The images were then changed to 8-bit format by
useofImageJsoftware(NIH).Thepreviouslyimprintedrulerwasusedto
set a pixel/m scale, and the line tool was used to measure the longest
dimension for each PML-NB. All statistical analyses were performed us-
ing the Student t test.
Fluorescent in situ hybridization (FISH). The hybridization probe
was prepared using the pBR322-Dunlop plasmid (54). DNA was labeled
with Cy3-dCTP using a nick translation kit (GE Healthcare) according to
the manufacturer’s instructions, and the unincorporated dye was re-
movedwithaMicroBio-Spin30spincolumn(Bio-Rad).Cellswereﬁxed
and washed with PBS as described above. Samples were treated with
5 g/ml DNase-free RNase at 37°C for 1 h. After three washes with PBS,
the cells were incubated with prehybridization buffer (50% formamide,
10% dextran sulfate, 4 SSC [1 SSC is 0.15 M NaCl plus 0.015 M
sodium citrate]) at 37°C for 30 min. Labeled probe was diluted in the
prehybridization buffer with 50 g/ml salmon sperm DNA (Invitrogen)
to 1 g/ml. Both the probes and the samples were denatured at 95°C for
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humidiﬁed chamber. After hybridization, the samples were washed with
2 SSC, once at 60°C for 5 min and then once at RT for 5 min. The
sampleswerethensubjectedtoimmunostainingandconfocalmicroscopy
as described above.
Retrovirus/lentivirus production and shRNA knockdown. To pro-
duce replication-deﬁcient Moloney murine leukemia virus-based retro-
viruses, 293T cells were cotransfected with pSIREN-RetroQ plasmids
along with packaging plasmids pLP/VSVG and pUMVC3-gag-pol at a
ratio of 1.5:1.5:1, with a total of 12 g DNA per 10-cm dish, using
TransIT-LT1 reagents (Mirus) according to the manufacturer’s recom-
mendations. Lentivirus expressing TAg was produced similarly by trans-
fecting 293TT cells with plasmids pMDLg-pRRE, pRSV-Rev, pCI-VSVG,
and pLL-puro at a ratio of 1:1:1:2. Retrovirus- or lentivirus-containing
supernatants were harvested at 3 days posttransfection and concentrated
100usingaLenti-Xconcentrator(Clontech)accordingtothemanufac-
turer’s instructions.
RPTE cells were infected with retroviruses or lentiviruses in the pres-
ence of 8 g/ml Polybrene (10 l concentrated virus per well of a 12-well
plate) for6ha t37°C. The viral inoculum was replaced with fresh REGM,
and the cells were selected with 3.1 g/ml puromycin beginning at 2 dpi.
The cells were infected with BKV 3 days after puromycin selection.
Lentivirus-infected cells were ﬁxed at 3 dpi and immunostained for PML
and TAg as described above.
Real-timePCR.ToquantifytheviralDNAloadincells,low-molecular-
weight DNA was isolated using a modiﬁed Hirt protocol (58) in which the
viral DNA was further puriﬁed using a QIAquick PCR puriﬁcation kit (Qia-
gen) after removal of the chromosomal DNA. Primers were designed to am-
plify 152- and 164-base-pair fragments of the TAg (TAg-Forward, 5=AAGG
AAAGGCTGGATTCTGA 3=; TAg-Reverse, 5= TGTGATTGGGATTCAGT
GCT 3=) and mitochondrial 16s rRNA (Mitochondrial 16s rRNA-Forward,
5= GAGGAACAGCTCTTTGGACA 3=; Mitochondrial 16s rRNA-Reverse,
5= CAATTGGGTGTGAGGAGTTC 3=), respectively. Real-time PCRs were
performed in a total volume of 25 l using 12.5 l Power SYBR green PCR
master mix (Applied Biosystems), 2.5 l DNA template, and 300 nM each
primer.Ampliﬁcationwasperformedin96-wellPCRplatesusingtheiCycler
iQ5real-timedetectionsystem(Bio-Rad)withthefollowingprogram:2min
at 50°C, 10 min at 95°C, 40 cycles of denaturation at 95°C for 15 s, and
annealingandextensionat58°Cfor30s.Resultsarepresentedastherelative
BKV DNA levels, with the levels in samples infected with an MOI of 0.1 IU/
cell at 2 dpi arbitrarily set to 1. Results were normalized to the levels of mito-
chondrial DNA present using the threshold cycle (2–CT; Livak) method
(54).
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